Editorial
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma
Abstract
Adrenocortical carcinoma (ACC) is an aggressive and extremely rare malignancy with an estimated incidence of 0.7–2.0 cases/million/population/year (1).
